Hyung Lae Kim, MD
Associate Director, Surgical Research, Samuel Oschin Comprehensive Cancer Institute
Director, Academic Programs, Urology
Co-Medical Director, Urologic Oncology Program
Hyung Lae Kim, MD is Associate Director for Surgical Research at the Samuel Oschin Comprehensive Cancer Institute, Director of Academic Programs for Urology and Co-Medical Director of the Urologic Oncology Program, at Cedars-Sinai.
Dr. Kim’s clinical practice focuses on treating cancers of the prostate, bladder, kidney and testis. He has extensive experience applying minimally invasive and robotic surgical techniques, and has published methods for improving the surgical management of urologic cancers. He is actively involved in developing and running innovative clinical trials that utilize novel treatment approaches. He is the principal investigator on multiple NIH grants. His research efforts are focused on two areas: developing new strategies for stimulating an immune response against cancer and developing better diagnostic tools that use genetic and molecular profiles.
He has published more than 100 original papers, reviews and book chapters, and has presented talks all over the United States. He is a regular reviewer for multiple journals, including Oncology, Journal of Urology, Urology, Cancer, Cancer Research, and Journal of Clinical Oncology.
Dr. Kim graduated with a bachelor’s degree and High Honors from the University of Michigan before earning his medical degree from the University of Chicago’s Pritzker School of Medicine. He continued his training with a residency in urology at the University of Chicago before completing two fellowships at the University of California, Los Angeles, in urologic oncology and in minimally invasive surgery. Before joining the staff at Cedars-Sinai Medical Center, Dr. Kim was Associate Professor and Vice Chair of Urology at the Roswell Park Cancer Institute in Buffalo, New York.